JC
THRD

JBF Capital’s Third Harmonic Bio THRD Stock Holding History

JBF Capital’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-250,000
Closed -$7.5K – 94
2025
Q3 		$7.5K Buy
+250,000
New +$1.36M ﹤0.01% 78

Other funds holding THRD

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

JBF Capital's THRD Position: Q4 2025 in Review

JBF Capital sold out of Third Harmonic Bio (THRD) in Q4 2025, closing a stake of 250,000 shares — an estimated $7.5K sold.

JBF Capital first reported a position in THRD in Q3 2025 and held it in 1 quarter. The position peaked at $7.5K in Q3 2025. 4 funds tracked by Wall St. Rank hold THRD as of Q4 2025.

  • JBF Capital reported no remaining Third Harmonic Bio position as of Q4 2025 after selling out during the quarter.
  • JBF Capital sold 250,000 Third Harmonic Bio shares in Q4 2025, an estimated $7.5K.
  • JBF Capital first reported a position in Third Harmonic Bio in Q3 2025 and held it in 1 quarter.
  • JBF Capital's Third Harmonic Bio position peaked at $7.5K in Q3 2025.
  • 4 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q4 2025.

Based on JBF Capital's 13F filing for Q4 2025, filed 12 Feb 2026.